Halozyme Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DLD ASSET MANAGEMENT, LP | 11/13/2025 | 30.00 M | $42.34 M | 140.00% | 24.72% |
| BLACKROCK, INC. | 11/12/2025 | 12.86 M | $943.17 M | -2.57% | 10.60% |
| VANGUARD GROUP INC | 11/07/2025 | 11.63 M | $852.93 M | -5.03% | 9.58% |
| STATE STREET CORP | 11/14/2025 | 5.02 M | $368.11 M | -15.43% | 4.14% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 3.29 M | $241.34 M | 29.49% | 2.71% |
| INVESCO LTD. | 11/13/2025 | 3.25 M | $238.04 M | -6.35% | 2.67% |
| UBS GROUP AG | 11/13/2025 | 2.95 M | $216.04 M | 93.24% | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 11/12/2025 | 2.73 M | $200.50 M | -19.54% | 2.25% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 2.65 M | $194.38 M | 160.15% | 2.18% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.43 M | $178.34 M | -0.05% | 2.00% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 2.08 M | $152.43 M | 3.16% | 1.71% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.98 M | $144.93 M | -4.44% | 1.63% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 1.91 M | $139.89 M | -22.32% | 1.57% |
| MORGAN STANLEY | 11/14/2025 | 1.74 M | $127.44 M | -1.75% | 1.43% |
| MACQUARIE GROUP LTD | 11/13/2025 | 1.55 M | $113.40 M | -25.79% | 1.27% |
| FEDERATED HERMES, INC. | 11/03/2025 | 1.45 M | $106.39 M | 294.14% | 1.20% |
| CONGRESS ASSET MANAGEMENT CO /MA | 10/10/2025 | 1.44 M | $105.36 M | -21.73% | 1.18% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 11/13/2025 | 1.37 M | $100.56 M | 10.31% | 1.13% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 1.32 M | $96.51 M | 199.18% | 1.08% |
| LSV ASSET MANAGEMENT | 11/06/2025 | 1.27 M | $92.85 M | 0.86% | 1.04% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 1.26 M | $92.54 M | -11.43% | 1.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.26 M | $92.51 M | -6.07% | 1.04% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.23 M | $90.03 M | 77.79% | 1.01% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 10/28/2025 | 1.23 M | $89.85 M | -5.17% | 1.01% |
| GROUPAMA ASSET MANAGMENT | 12/01/2025 | 1.20 M | $1.69 M | 0.00% | 0.99% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.17 M | $85.60 M | 9.45% | 0.96% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 11/13/2025 | 1.14 M | $83.85 M | 3.75% | 0.94% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 10/20/2025 | 1.08 M | $79.29 M | 11.03% | 0.89% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.08 M | $78.94 M | 23.20% | 0.89% |
| JANE STREET GROUP, LLC | 11/14/2025 | 1.08 M | $78.87 M | 11.21% | 0.89% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 1.06 M | $77.59 M | 100.00% | 0.87% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 1.05 M | $77.23 M | 16.62% | 0.87% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 1.04 M | $75.92 M | -5.10% | 0.85% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.00 M | $73.36 M | 195.39% | 0.82% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 968.51 K | $71.03 M | 155.68% | 0.80% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 958.03 K | $70.26 M | 5.23% | 0.79% |
| ROYAL BANK OF CANADA | 11/14/2025 | 950.85 K | $69.74 M | 79.43% | 0.78% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 924.88 K | $67.83 M | 6.69% | 0.76% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 898.19 K | $65.87 M | -10.42% | 0.74% |
| BOSTON TRUST WALDEN CORP | 10/17/2025 | 833.89 K | $61.16 M | -1.34% | 0.69% |
| CAPITAL WORLD INVESTORS | 11/13/2025 | 831.66 K | $60.99 M | 6.35% | 0.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 825.43 K | $60.54 M | -20.03% | 0.68% |
| JUPITER ASSET MANAGEMENT LTD | 11/10/2025 | 800.58 K | $58.71 M | 19.38% | 0.66% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 776.99 K | $56.98 M | 189.45% | 0.64% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 11/14/2025 | 776.64 K | $56.96 M | -42.09% | 0.64% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 776.41 K | $56.94 M | 1.37% | 0.64% |
| JPMORGAN CHASE & CO | 11/26/2025 | 767.84 K | $56.31 M | -25.85% | 0.63% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 684.52 K | $50.20 M | -49.95% | 0.56% |
| NUVEEN, LLC | 11/12/2025 | 653.12 K | $47.90 M | 35.95% | 0.54% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 623.03 K | $45.69 M | -6.94% | 0.51% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Halozyme Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 822 institutional investors and hedge funds held shares of Halozyme Therapeutics, Inc.. The most heavily invested institutionals were:
DLD Asset Management, LP: 30 M
BlackRock, Inc.: 12.86 M
VANGUARD GROUP INC: 11.63 M
STATE STREET CORP: 5.02 M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 3.29 M
Invesco Ltd.: 3.25 M
123.94% of Halozyme Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 203.75 M shares in the last 24 months. This purchase volume represents approximately $14.05 B in transactions.